Eli Lilly has partnered with Boston’s Ascidian to develop RNA exon‑editing therapies for inherited kidney diseases in a deal that could be worth up to $1.9 billion. The collaboration pairs Ascidian’s platform with Lilly’s Seaport genetic‑medicine hub.

NSF is removing instruments from the Ocean Observatories Initiative, ending key below‑surface measurements off the Pacific Northwest as El Niño approaches.

Justice Department files show Jeffrey Epstein deposited sperm with California Cryobank and signed a 2016 contract leaving the samples to his estate; the material’s whereabouts remain unclear.

The Allen Institute unveiled a $400M Brain Health accelerator to map vulnerable brain cells and speed therapies for Alzheimer’s, Parkinson’s, Huntington’s and ALS.

Dr. Pradeep Y. Ramulu, a Bascom Palmer alumnus and Johns Hopkins glaucoma chief, will return to Miami to lead Bascom Palmer beginning Aug. 3, 2026. He brings a research focus on how glaucoma affects daily life.

After pausing in February, Redwood City ad‑tech Liftoff Mobile relaunched a smaller IPO that would raise about $399M. The offering will test appetite for AI‑driven ad tech.

Gabe Newell’s Inkfish has contracted Norwegian yard Vard for a €700M (≈$814M), 162‑meter research ship built for ultra‑deep seafloor mapping and submersible operations.

Jefferson University will open Delaware’s first medical school in partnership with the University of Delaware, backed by roughly $157 million in federal rural‑health funds.

Voyager agreed to buy Astrobotic in a deal worth up to $300M, folding the Pittsburgh Moon Base HQ into Voyager's lunar program.

AI news and big IPO filings sent markets to fresh highs Monday, with Micron topping $1,000 and Anthropic filing for an IPO.

Bloomberg reports Alphabet is lining up an $80B equity program — ATM sales, underwritten offerings and a Berkshire‑backed private placement — to pay for massive AI buildout.

A Dallas Fed survey finds two-thirds of Texas companies use AI; a small share say it lowered their need for workers.

Pat Madden’s Phoenix startup Deus X Defense says it merged drones, guards and sensors into one managed offering and counts about 500 staff after two acquisitions.